ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,673.96
0.31%
Dow Jones
44,544.66
-0.75%
Gold vs US Dollar
2,798.49
0.00%
Brent Oil
76.385
0.00%
Bitcoin
99,607.79
-1.05%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Ovid Therapeutics Inc (OVID) Share Price

OVID Ovid Therapeutics Inc

0.6966
-0.0035 (-0.50%)
01 Feb 2025 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Ovid Therapeutics Inc NASDAQ:OVID NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.0035 -0.50 0.6966 0.665 0.705 0.7218 0.66 0.7198 517,535 00:56:33   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 392k -52.34M -0.7371 -0.90 49.71M
 Type  Size  Price  Time  Units 
 20 1,000 0.6966 00:36:42 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore OVID News
29/01/202514:18EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
16/12/202421:15EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
16/12/202421:15EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
02/12/202413:00GLOBEOvid Therapeutics to Present Multiple Posters Supporting Its Pipeline Programs Targeting Neuronal Hyperexcitability at the American Epilepsy Society 2024 Annual Meeting
12/11/202413:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202413:03EDGAR2Form 8-K - Current report
12/11/202413:00GLOBEOvid Therapeutics Reports Business Updates and Third Quarter 2024 Financial Results
Period
Draw mode
Data Downloads for OVID

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Ovid Therapeutics Inc Articles

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads